• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年皮肌炎患者中柯萨奇B病毒抗体的患病率。

Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis.

作者信息

Christensen M L, Pachman L M, Schneiderman R, Patel D C, Friedman J M

出版信息

Arthritis Rheum. 1986 Nov;29(11):1365-70. doi: 10.1002/art.1780291109.

DOI:10.1002/art.1780291109
PMID:3022759
Abstract

A number of viruses have been implicated as being the cause of various forms of myositis, including acute transient myositis, chronic polymyositis, and dermatomyositis. However, the cause of juvenile dermatomyositis (JDM) has remained elusive. Our study of serum samples taken within 4 months of the onset of disease in 12 children with JDM showed that 83% had detectable titers of complement-fixing (CF) antibody to 1 or more coxsackie B viral antigens. Detectable titers were found in only 25% of age-, sex-, and date-matched control sera taken from 24 patients with juvenile rheumatoid arthritis (JRA), and in 25% of serum samples taken from 2,192 "normal" children who had been hospitalized because of viral syndromes. Titers of CF antibody to coxsackie B1, B2, and B4 were positive in 58%, 50%, and 58%, respectively, of the JDM patients. In matched JRA controls, the respective values were 8%, 13%, and 8%. There were no significant antiviral titers and no significant differences in the results of tests for 13 other viral CF antigens, hepatitis B surface antigen, and Mycoplasma pneumoniae CF antigen in the JDM patient sera compared with the JRA patient sera. When titers of neutralizing antibody were determined, 58%, 58%, and 67% of the JDM patients were positive for coxsackie B2, B4, and B5, respectively, whereas 16%, 26%, and 21%, respectively, of the JRA controls were positive for the 3 antigens. These data suggest that the host response to coxsackie B virus might be related to the pathophysiology of JDM.

摘要

多种病毒被认为是各种形式肌炎的病因,包括急性短暂性肌炎、慢性多发性肌炎和皮肌炎。然而,青少年皮肌炎(JDM)的病因仍不清楚。我们对12例JDM患儿在发病4个月内采集的血清样本进行研究,结果显示,83%的患儿针对1种或多种柯萨奇B病毒抗原的补体结合(CF)抗体滴度可检测到。在24例青少年类风湿性关节炎(JRA)患者中,按年龄、性别和日期匹配的对照血清中只有25%可检测到抗体滴度,在2192例因病毒综合征住院的“正常”儿童的血清样本中,这一比例为25%。JDM患者中,针对柯萨奇B1、B2和B4的CF抗体滴度分别有58%、50%和58%呈阳性。在匹配的JRA对照中,相应的值分别为8%、13%和8%。与JRA患者血清相比,JDM患者血清中针对其他13种病毒CF抗原、乙肝表面抗原和肺炎支原体CF抗原的检测结果,抗病毒滴度无显著差异。当检测中和抗体滴度时,JDM患者中分别有58%、58%和67%针对柯萨奇B2、B4和B5呈阳性,而JRA对照中针对这3种抗原呈阳性的比例分别为16%、26%和21%。这些数据表明,宿主对柯萨奇B病毒的反应可能与JDM的病理生理学有关。

相似文献

1
Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis.青少年皮肌炎患者中柯萨奇B病毒抗体的患病率。
Arthritis Rheum. 1986 Nov;29(11):1365-70. doi: 10.1002/art.1780291109.
2
New-onset juvenile dermatomyositis: comparisons with a healthy cohort and children with juvenile rheumatoid arthritis.
Arthritis Rheum. 1997 Aug;40(8):1526-33. doi: 10.1002/art.1780400822.
3
Virological study of idiopathic cardiomyopathy: serological study of virus antibodies and immunofluorescent study of myocardial biopsies.
Jpn Circ J. 1981 Mar;45(3):279-94. doi: 10.1253/jcj.45.279.
4
Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.胰岛素依赖型(青少年发病;I型)糖尿病患儿的柯萨奇B病毒特异性IgM反应
Lancet. 1983 Jun 25;1(8339):1397-9. doi: 10.1016/s0140-6736(83)92353-x.
5
[Neutralizing antibodies to Coxsackie virus group B 1986-1988].
Vojnosanit Pregl. 1990 Jul-Aug;47(4):294-6.
6
Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.幼年型系统性红斑狼疮患者外周血T和B淋巴细胞上Fas和Bcl-2表达增加,但幼年类风湿关节炎和幼年皮肌炎患者未出现这种情况。
Clin Dev Immunol. 2006 Jun-Dec;13(2-4):283-7. doi: 10.1080/17402520600877786.
7
Type 1 diabetes and Coxsackie virus infection.1型糖尿病与柯萨奇病毒感染。
Helv Paediatr Acta. 1979;34(6):557-61.
8
Coxsackievirus infection and the development of polymyositis/dermatomyositis.柯萨奇病毒感染与多发性肌炎/皮肌炎的发病
Rheumatol Int. 1994;14(2):43-6. doi: 10.1007/BF00300245.
9
Maternal and neonatal neutralizing antibody titers to selected enteroviruses.母体和新生儿针对特定肠道病毒的中和抗体滴度。
Pediatr Infect Dis. 1985 Jan-Feb;4(1):32-5. doi: 10.1097/00006454-198501000-00009.
10
Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia.英国、奥地利和澳大利亚青少年起病的胰岛素依赖型糖尿病患者中柯萨奇B病毒、腮腺炎病毒、风疹病毒和巨细胞病毒特异性IgM反应
Lancet. 1985 Jun 22;1(8443):1409-12. doi: 10.1016/s0140-6736(85)91843-4.

引用本文的文献

1
Soluble form of the MDA5 protein in human sera.人血清中MDA5蛋白的可溶性形式。
Heliyon. 2024 May 24;10(11):e31727. doi: 10.1016/j.heliyon.2024.e31727. eCollection 2024 Jun 15.
2
The relationship between infectious agents and juvenile dermatomyositis: a narrative update from the pediatric perspective.感染因子与青少年皮肌炎之间的关系:从儿科角度的叙述性更新
Front Immunol. 2024 Apr 10;15:1377952. doi: 10.3389/fimmu.2024.1377952. eCollection 2024.
3
[Current update on dermatomyositis].[皮肌炎的最新进展]
Dermatologie (Heidelb). 2024 Feb;75(2):153-162. doi: 10.1007/s00105-023-05273-9. Epub 2024 Jan 9.
4
Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy.特发性炎性肌病的病理生理学中的肌肉纤维坏死性细胞死亡及其作为新型治疗策略靶点的潜力。
Front Immunol. 2023 Jul 7;14:1191815. doi: 10.3389/fimmu.2023.1191815. eCollection 2023.
5
A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination - a Case Report.1例新冠病毒mRNA疫苗接种后出现快速进展性间质性肺病的MDA-5阳性无肌病性皮肌炎罕见病例——病例报告
SN Compr Clin Med. 2023;5(1):18. doi: 10.1007/s42399-022-01357-0. Epub 2022 Dec 7.
6
Transcriptomes of peripheral blood mononuclear cells from juvenile dermatomyositis patients show elevated inflammation even when clinically inactive.来自青少年皮肌炎患者外周血单核细胞的转录组显示,即使在临床无活动期,炎症也升高。
Sci Rep. 2022 Jan 7;12(1):275. doi: 10.1038/s41598-021-04302-8.
7
Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-Based Cohort Study.特发性炎性肌病的发病率、患病率和死亡率:一项基于人群的队列研究。
Arthritis Care Res (Hoboken). 2023 Feb;75(2):348-355. doi: 10.1002/acr.24786. Epub 2022 Oct 6.
8
Juvenile Dermatomyositis: New Clues to Diagnosis and Therapy.青少年皮肌炎:诊断与治疗的新线索
Curr Treatm Opt Rheumatol. 2021 Mar;7(1):39-62. doi: 10.1007/s40674-020-00168-5. Epub 2021 Feb 6.
9
Myositis-Related Interstitial Lung Disease: A Respiratory Physician's Point of View.肌炎相关性间质性肺病:呼吸科医师的观点。
Medicina (Kaunas). 2021 Jun 10;57(6):599. doi: 10.3390/medicina57060599.
10
Environmental triggers of dermatomyositis: a narrative review.皮肌炎的环境触发因素:一项叙述性综述。
Ann Transl Med. 2021 Mar;9(5):434. doi: 10.21037/atm-20-3719.